GABA-B RECEPTORS AND PARKINSON'S DISEASE

GABA-B 受体与帕金森病

基本信息

  • 批准号:
    8172313
  • 负责人:
  • 金额:
    $ 4.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main goal of this project is to characterize the anatomical and functional organization of basal ganglia GABA-B receptors in normal and parkinsonian conditions. During the past funding period, efforts have been devoted towards the understanding of the role GABA transporters (GATs) may play in regulating GABA-B receptors activation in the pallidal complex of normal and parkinsonian nonhuman primates. These experiments were complemented with in vitro electrophysiological studies in rat brain slices to further understand the synaptic mechanisms by which GAT blockade modulates activity of pre- and postsynaptic GABA-B receptors in the globus pallidus. The following conclusions can be made from these studies: (1) The subcellular localization of GATs in both the internal and external pallidal segments (GPi, GPe) is not affected in parkinsonian condition. Using in vivo electrophysiology recording procedures in awake monkeys combined with local drug delivery in GPe and GPi, we demonstrated that the effects of GAT-1 or GAT-3 blockade were similar to those seen in normal monkeys in the GPe, but unlike the findings in the normal state, the firing of most neurons was not affected by blockade of either transporter in GPi. These results suggest that, after dopaminergic depletion, the functions of GABA transporters are altered in GPi; without major changes in their subcellular localization. (2) Using in vitro slice electrophysiology, we have also demonstrated that both GABA transporters, GAT-1 and GAT-3, significantly regulate GABAA-receptor mediated GABAergic synaptic transmission in the rat GP, thereby providing evidence for the high expression level and functional importance of GATs in regulating GABAergic striatopallidal transmission. Knowing the importance of increased striatal GABAergic outflow to the GP in the pathophysiology of Parkinson's disease, GATs may be considered as potential targets for the future development of antiparkinsonian agents that could increase GAT-1- or GAT-3-mediated GABA reuptake functions in pathological conditions.
该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员(PI)可能已经从其他NIH来源获得了主要资金, 因此可以在其他清晰的条目中代表。列出的机构是 对于中心,这不一定是调查员的机构。 该项目的主要目的是表征正常和帕金森氏症状况下基底神经节GABA受体的解剖和功能组织。在过去的资金期间,努力旨在理解GABA转运蛋白(GAT)在调节正常和帕金森氏症非人类灵长类动物的苍白体复合物中的GABA-B受体激活方面发挥作用。这些实验与大鼠脑切片中的体外电生理研究相辅相成,以进一步了解GAT阻断调节球pallidus的突触前和突触后GABA-B受体的活性的突触机制。 从这些研究中可以得出以下结论:(1)在帕金森氏症情况下,内部和外部苍白球段(GPI,GPE)在内部和外部苍白球段(GPI,GPE)中的亚细胞定位均未影响。 Using in vivo electrophysiology recording procedures in awake monkeys combined with local drug delivery in GPe and GPi, we demonstrated that the effects of GAT-1 or GAT-3 blockade were similar to those seen in normal monkeys in the GPe, but unlike the findings in the normal state, the firing of most neurons was not affected by blockade of either transporter in GPi. 这些结果表明,在多巴胺能消耗后,GPI中GABA转运蛋白的功能发生了改变。没有重大变化的亚细胞定位。 (2)使用体外切片电生理学,我们还证明了GABA转运蛋白GAT-1和GAT-3都显着调节了大鼠GP中GABAA受体受体介导的GABAergic Synaptic Transpormation,从而提供了GAT在调节Gabaergriat striat striatal striatal striatal striatal striatal striatal striatal striatal striatal striatal striatal striatal striatal striat palliatal striat palliat palliat palliatial palliatialiD的证据。知道帕金森氏病的病理生理学中纹状体GABA能流出对GP的重要性,GAT可能被认为是抗帕金森氏病毒未来发展的潜在靶标,这些靶标可能会在病理条件下增加GAT-1-或GAT-3介导的GABA介导的GABA重摄取功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yoland Smith其他文献

Yoland Smith的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yoland Smith', 18)}}的其他基金

Connectome of Motor Corticofugal Neurons in Parkinsonian Monkeys
帕金森猴运动皮质神经元的连接组
  • 批准号:
    10284849
  • 财政年份:
    2021
  • 资助金额:
    $ 4.39万
  • 项目类别:
Connectome of Motor Corticofugal Neurons in Parkinsonian Monkeys
帕金森猴运动皮质神经元的连接组
  • 批准号:
    10495224
  • 财政年份:
    2021
  • 资助金额:
    $ 4.39万
  • 项目类别:
Pathophysiology of the Pedunculopontine Nucleus in Parkinson's Disease
帕金森病桥脚核的病理生理学
  • 批准号:
    10213844
  • 财政年份:
    2017
  • 资助金额:
    $ 4.39万
  • 项目类别:
Pathophysiology of the Pedunculopontine Nucleus in Parkinson's Disease
帕金森病桥脚核的病理生理学
  • 批准号:
    9975917
  • 财政年份:
    2017
  • 资助金额:
    $ 4.39万
  • 项目类别:
Pathophysiology of the Pedunculopontine Nucleus in Parkinson's Disease
帕金森病桥脚核的病理生理学
  • 批准号:
    9404759
  • 财政年份:
    2017
  • 资助金额:
    $ 4.39万
  • 项目类别:
A2AR/MGLUR5 ANTAGONIST COMBINATION ANTIPARKINSONIAN THERAPY IN MPTP MONKEYS
A2AR/MGLUR5 拮抗剂联合抗帕金森病治疗 MPTP 猴
  • 批准号:
    8357543
  • 财政年份:
    2011
  • 资助金额:
    $ 4.39万
  • 项目类别:
GABA-B RECEPTORS AND PARKINSON'S DISEASE
GABA-B 受体与帕金森病
  • 批准号:
    8357385
  • 财政年份:
    2011
  • 资助金额:
    $ 4.39万
  • 项目类别:
THE THALAMOSTRIATAL SYSTEM IN PRIMATES
灵长类动物的丘脑纹状体系统
  • 批准号:
    8357447
  • 财政年份:
    2011
  • 资助金额:
    $ 4.39万
  • 项目类别:
ANATOMICAL AND PHYSIOLOGICAL CHARACTERIZATION OF THE THALAMOSTRIATAL SYSTEM
丘纹系统的解剖学和生理学特征
  • 批准号:
    8357545
  • 财政年份:
    2011
  • 资助金额:
    $ 4.39万
  • 项目类别:
BIOMARKERS FOR PRECLINICAL PARKINSON?S DISEASE
临床前帕金森病的生物标志物
  • 批准号:
    8357570
  • 财政年份:
    2011
  • 资助金额:
    $ 4.39万
  • 项目类别:

相似海外基金

The impact of exercise on subthalamic nucleus neural activity in Parkinson's disease
运动对帕金森病丘脑底核神经活动的影响
  • 批准号:
    10538708
  • 财政年份:
    2022
  • 资助金额:
    $ 4.39万
  • 项目类别:
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
埃默里大学莫里斯·尤德尔帕金森病研究卓越中心
  • 批准号:
    10284843
  • 财政年份:
    2021
  • 资助金额:
    $ 4.39万
  • 项目类别:
Connectome of Motor Corticofugal Neurons in Parkinsonian Monkeys
帕金森猴运动皮质神经元的连接组
  • 批准号:
    10284849
  • 财政年份:
    2021
  • 资助金额:
    $ 4.39万
  • 项目类别:
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
埃默里大学莫里斯·尤德尔帕金森病研究卓越中心
  • 批准号:
    10495205
  • 财政年份:
    2021
  • 资助金额:
    $ 4.39万
  • 项目类别:
Parkinsonism-Related Changes in Activity of Cortical Projection Neurons in Monkeys
猴子皮质投射神经元活动与帕金森症相关的变化
  • 批准号:
    10284848
  • 财政年份:
    2021
  • 资助金额:
    $ 4.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了